Developmental Genotype-Tissue Expression Project

Developmental Genotype-Tissue Expression Project
Establishing the first comprehensive database of healthy pediatric tissue gene expression to understand genetic influences on childhood development and diseases.
About
What does Developmental Genotype-Tissue Expression Project do?
The Developmental Genotype-Tissue Expression Project (dGTEx) is a major initiative by the National Institutes of Health (NIH) focused on creating a comprehensive database and tissue bank of healthy pediatric tissue. It aims to map how genes are expressed across various tissues and developmental stages in children, providing a crucial resource for understanding genetic variations' impact on complex traits and diseases. The project also includes a non-human primate component for comparative studie…
Is Developmental Genotype-Tissue Expression Project trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Developmental Genotype-Tissue Expression Project is 65 out of 100, based on site security posture and privacy practices.
What is Developmental Genotype-Tissue Expression Project's revenue?
StartupHub estimates Developmental Genotype-Tissue Expression Project's annual revenue at $4.9M (range $1.4M to $20.0M, 34% confidence), based on comparable companies in the sector.
What is Developmental Genotype-Tissue Expression Project's valuation?
StartupHub estimates Developmental Genotype-Tissue Expression Project's effective valuation at $154.8M (range $96.3M to $231.0M, 10% confidence), based on comparable companies in the sector.
How much funding has Developmental Genotype-Tissue Expression Project raised?
Developmental Genotype-Tissue Expression Project has raised a total of $39M in funding. The most recent round on record is Grant.
Where is Developmental Genotype-Tissue Expression Project headquartered?
Developmental Genotype-Tissue Expression Project is headquartered in Philadelphia, United States.
When was Developmental Genotype-Tissue Expression Project founded?
Developmental Genotype-Tissue Expression Project was founded in 2021.
What industry does Developmental Genotype-Tissue Expression Project operate in?
Developmental Genotype-Tissue Expression Project operates in Biotechnology, Healthcare, Genomics, Data Science, Bioinformatics, Pediatric Healthcare.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.

